The observed reversal of tumor cell biological functions upon manipulation of c-Met expression further supports the notion that PTHrP’s pro-prostate cancer effects are at least partially mediated by its influence on c-Met activity and expression levels. This evidence concerns the gene MET and prostate cancer.